Serum inflammatory markers in obstructive sleep apnea: a meta-analysis

Area of Science:

• Cardiovascular Medicine
• Sleep Medicine
• Immunology

Background:

• Obstructive sleep apnea (OSA) is associated with increased cardiovascular and cerebrovascular risks.
• Chronic inflammatory responses are implicated in the link between OSA and associated morbidities.
• Existing studies on inflammatory markers in OSA are small, necessitating a comprehensive meta-analysis.

Purpose of the Study:

• To conduct a meta-analysis of existing studies to determine the profile of inflammatory markers in patients with obstructive sleep apnea.
• To quantitatively assess the levels of key inflammatory markers in OSA patients compared to control groups.

Main Methods:

• A systematic review of medical literature was performed using PubMed, Cochrane, and EMBASE databases (1968-2011).
• Keywords included obstructive sleep apnea and specific inflammatory markers (CRP, TNF-α, IL-6, IL-8, ICAM, VCAM, Selectins).
• Inclusion criteria involved full-text English articles, adult populations, reported marker values, control groups, and OSA defined by an apnea-hypopnea index (AHI) of ≥ 5/h.

Main Results:

• Fifty-one studies were included in the meta-analysis, with varying numbers of studies for each marker (e.g., 30 for CRP, 19 for TNF-α).
• Patients with OSA exhibited significantly higher levels of all assessed inflammatory markers compared to control subjects.
• Standardized pooled mean differences indicated substantial elevations, with IL-8 showing the highest (4.22) and TNF-α the lowest (1.03).

Conclusions:

• This meta-analysis demonstrates elevated systemic inflammatory marker levels in patients with obstructive sleep apnea.
• The findings reinforce the role of inflammation in the pathophysiology linking OSA to cardiovascular and cerebrovascular complications.
• Further research may explore targeted anti-inflammatory therapies for OSA management.